Skip to main content
. 2021 Nov 30;10(23):e021873. doi: 10.1161/JAHA.121.021873

Table 2.

Relative Risk of All‐Cause Mortality, According to AT/ET

Variable All‐cause mortality
Outcome under conservative management HR (95% CI) P value
Univariate analysis
AT/ET per increment of 0.01 1.09 (1.04–1.16) <0.001
AT/ET ≤0.35 Reference
AT/ET >0.35 2.44 (1.39–4.29) <0.001
Multivariable model (n=230)*
AT/ET per increment of 0.01 1.11 (1.04–1.18) 0.002
AT/ET ≤0.35 Reference
AT/ET >0.35 3.29 (1.70–6.39) <0.001
Outcome under medical and/or surgical management Adjusted HR (95% CI) P value
Univariate analysis
AT/ET per increment of 0.01 1.06 (1.01–1.11) 0.018
AT/ET ≤0.35 Reference
AT/ET >0.35 1.89 (1.16–3.08) 0.010
Multivariable model without AVR (n=347)*
AT/ET per increment of 0.01 1.08 (1.02–1.14) 0.009
AT/ET ≤0.35 Reference
AT/ET >0.35 2.34 (1.36–4.03) 0.002
Multivariable model with AVR (n=347)
AT/ET per increment of 0.01 1.09 (1.03–1.15) 0.004
AT/ET ≤0.35 Reference
AT/ET >0.35 2.54 (1.47–4.37) <0.001

AT/ET indicates ratio of acceleration time/ejection time; AVR, aortic valve replacement; and HR, hazard ratio.

*

Multivariable model is adjusted for age, sex, systolic blood pressure, Charlson comorbidity index (without including age), history of atrial fibrillation, peak aortic jet velocity, left ventricular stroke volume index, and left ventricular ejection fraction.

Model is adjusted for covariates included in the model without AVR and AVR as time‐dependent covariate.